Cargando…

Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer

BACKGROUND: Automated breast ultrasound (ABUS) is a useful choice in breast disease diagnosis. The axillary lymph node (ALN) status is crucial for predicting the clinical classification and deciding on the treatment of early-stage breast cancer (EBC) and could be the primary indicator of locoregiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiucheng, Li, Bo, Liu, Zhao, Shang, Haitao, Jing, Hui, Shao, Hua, Chen, Kexin, Liang, Xiaoshuan, Cheng, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420256/
https://www.ncbi.nlm.nih.gov/pubmed/36031602
http://dx.doi.org/10.1186/s12885-022-10034-3
_version_ 1784777351948664832
author Wang, Qiucheng
Li, Bo
Liu, Zhao
Shang, Haitao
Jing, Hui
Shao, Hua
Chen, Kexin
Liang, Xiaoshuan
Cheng, Wen
author_facet Wang, Qiucheng
Li, Bo
Liu, Zhao
Shang, Haitao
Jing, Hui
Shao, Hua
Chen, Kexin
Liang, Xiaoshuan
Cheng, Wen
author_sort Wang, Qiucheng
collection PubMed
description BACKGROUND: Automated breast ultrasound (ABUS) is a useful choice in breast disease diagnosis. The axillary lymph node (ALN) status is crucial for predicting the clinical classification and deciding on the treatment of early-stage breast cancer (EBC) and could be the primary indicator of locoregional recurrence. We aimed to establish a prediction model using ABUS features of primary breast cancer to predict ALN status. METHODS: A total of 469 lesions were divided into the axillary lymph node metastasis (ALNM) group and the no ALNM (NALNM) group. Univariate analysis and multivariate analysis were used to analyze the difference of clinical factors and ABUS features between the two groups, and a predictive model of ALNM was established. Pathological results were as the gold standard. RESULTS: Ki-67, maximum diameter (MD), posterior feature shadowing or enhancement and hyperechoic halo were significant risk factors for ALNM in multivariate logistic regression analysis (P < 0.05). The four risk factors were used to build the predictive model, and it achieved an area under the receiver operating characteristic (ROC) curve (AUC) of 0.791 (95% CI: 0.751, 0.831). The accuracy, sensitivity and specificity of the prediction model were 72.5%, 69.1% and 75.26%. The positive predictive value (PPV) and negative predictive value (NPV) were 66.08% and 79.93%, respectively. Distance to skin, MD, margin, shape, internal echo pattern, orientation, posterior features, and hyperechoic halo showed significant differences between stage I and stage II (P < 0.001). CONCLUSION: ABUS features and Ki-67 can meaningfully predict ALNM in EBC and the prediction model may facilitate a more effective therapeutic schedule. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10034-3.
format Online
Article
Text
id pubmed-9420256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94202562022-08-29 Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer Wang, Qiucheng Li, Bo Liu, Zhao Shang, Haitao Jing, Hui Shao, Hua Chen, Kexin Liang, Xiaoshuan Cheng, Wen BMC Cancer Research BACKGROUND: Automated breast ultrasound (ABUS) is a useful choice in breast disease diagnosis. The axillary lymph node (ALN) status is crucial for predicting the clinical classification and deciding on the treatment of early-stage breast cancer (EBC) and could be the primary indicator of locoregional recurrence. We aimed to establish a prediction model using ABUS features of primary breast cancer to predict ALN status. METHODS: A total of 469 lesions were divided into the axillary lymph node metastasis (ALNM) group and the no ALNM (NALNM) group. Univariate analysis and multivariate analysis were used to analyze the difference of clinical factors and ABUS features between the two groups, and a predictive model of ALNM was established. Pathological results were as the gold standard. RESULTS: Ki-67, maximum diameter (MD), posterior feature shadowing or enhancement and hyperechoic halo were significant risk factors for ALNM in multivariate logistic regression analysis (P < 0.05). The four risk factors were used to build the predictive model, and it achieved an area under the receiver operating characteristic (ROC) curve (AUC) of 0.791 (95% CI: 0.751, 0.831). The accuracy, sensitivity and specificity of the prediction model were 72.5%, 69.1% and 75.26%. The positive predictive value (PPV) and negative predictive value (NPV) were 66.08% and 79.93%, respectively. Distance to skin, MD, margin, shape, internal echo pattern, orientation, posterior features, and hyperechoic halo showed significant differences between stage I and stage II (P < 0.001). CONCLUSION: ABUS features and Ki-67 can meaningfully predict ALNM in EBC and the prediction model may facilitate a more effective therapeutic schedule. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10034-3. BioMed Central 2022-08-28 /pmc/articles/PMC9420256/ /pubmed/36031602 http://dx.doi.org/10.1186/s12885-022-10034-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Qiucheng
Li, Bo
Liu, Zhao
Shang, Haitao
Jing, Hui
Shao, Hua
Chen, Kexin
Liang, Xiaoshuan
Cheng, Wen
Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
title Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
title_full Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
title_fullStr Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
title_full_unstemmed Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
title_short Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
title_sort prediction model of axillary lymph node status using automated breast ultrasound (abus) and ki-67 status in early-stage breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420256/
https://www.ncbi.nlm.nih.gov/pubmed/36031602
http://dx.doi.org/10.1186/s12885-022-10034-3
work_keys_str_mv AT wangqiucheng predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT libo predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT liuzhao predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT shanghaitao predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT jinghui predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT shaohua predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT chenkexin predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT liangxiaoshuan predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer
AT chengwen predictionmodelofaxillarylymphnodestatususingautomatedbreastultrasoundabusandki67statusinearlystagebreastcancer